Edit
Momenta Pharmaceuticals
https://www.momentapharma.com/home/default.aspxLast activity: 02.09.2020
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Investors 4
| Date | Name | Website |
| - | Old Silver... | oldsilverv... |
| - | Omega Fund... | omegafunds... |
| - | Atlas Vent... | atlasventu... |
| - | Cardinal P... | cardinalpa... |
Mentions in press and media 9
| Date | Title | Description | Source |
| 02.09.2020 | August M&A: Netcapital merges with ValueSetters, Kronos ... | This wasn't a particularly hot month for M&A activity in Boston, with a handful of deals crowded... | bizjournal... |
| 19.08.2020 | Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 bi... | Momenta Pharmaceuticals surged as much as 69% on Wednesday after reaching an agreement to be acquire... | businessin... |
| 13.02.2018 | Novartis, Momenta grab a delayed FDA OK for blockbuste... | After a long delay, Momenta $MNTA and Novartis $NVS have finally received an FDA green lig... | endpts.com... |
| 21.02.2017 | Bad news for Momenta and Pfizer is a much-needed blessing fo... | File this under “reversal of fortunes.” Late last Friday, Momenta Pharmaceuticals disclosed that a ... | statnews.c... |
| 27.09.2016 | Shire punts late-stage biosimilars of Humira and Enbrel... | Momenta CEO Craig Wheeler Just days after Amgen won an FDA approval for the first biosimila... | endpts.com... |
| 31.07.2013 | Pharma firm bets sialic acid could help explain link between... | It’s simultaneously developing two products: an antibody targeting solid tumors including ovarian, b... | medcitynew... |
| 13.08.2009 | Turmoil at the FDA? — MedCity Morning Read, Aug. 13, 2009 | Momenta says the co-authored paper represents a conflict of interest and asked that Woodcock excuse ... | medcitynew... |
| - | Pharma firm bets sialic acid could help explain link between... | A syndicate of East Coast angel investors pieced together $1 million to help a bicoastal startup com... | medcitynew... |
| - | Turmoil at the FDA? — MedCity Morning Read, Aug. 13, 2009 | WASHINGTON, D.C. — The inspector general of the U.S. Department of Health and Human Services is inve... | medcitynew... |